Gregory Burshtein
Insider Reports History
- Location
- Jerusalem, Israel
- Signature
- /s/ Dana Yaacov-Garbeli, Attorney-in-fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Gregory Burshtein:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Entera Bio Ltd. | Chief of R&D | Ordinary Shares, par value NIS 0.0000769 per share | 101,442 | $208,970 | $2.06 | 16 Jul 2025 | Direct |
| Entera Bio Ltd. | Chief of R&D | Stock Option (right to buy) | 200,000 | 16 Jul 2025 | Direct |
Insider Reports Filed by Gregory Burshtein
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENTX | Entera Bio Ltd. | 16 Jul 2025 | 2 | $0 | 4 | Chief of R&D | 18 Jul 2025, 16:35 |
| ENTX | Entera Bio Ltd. | 28 May 2024 | 0 | $0 | 3 | Chief of R&D | 07 Jun 2024, 16:05 |